Pacira BioSciences, Inc. ( PCRX) - Stock Earnings
Stock symbol PCRX is outdated, potentially delisted? Maybe it is available on other exchange?
PCRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -693000 USD | 167.5 million USD |
| 2022Q4 | -10.1 million USD | 172.0 million USD |
| 2023Q1 | -19.5 million USD | 160.3 million USD |
PCRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | 145.5 million USD | 429.6 million USD |
| 2021 | 42.0 million USD | 541.5 million USD |
| 2022 | 15.9 million USD | 666.8 million USD |
PCRX
Price: $28.29
52 week price:
Earnings Per Share: 3.95 USD
P/E Ratio: 119.03
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 331700
Ebitda: 936000Market Capitalization: 2.0 billion